Literature DB >> 28747449

Loss of cutaneous large and small fibers in naive and l-dopa-treated PD patients.

Maria Nolano1, Vincenzo Provitera2, Fiore Manganelli2, Rosa Iodice2, Annamaria Stancanelli2, Giuseppe Caporaso2, Annamaria Saltalamacchia2, Francesca Califano2, Bernardo Lanzillo2, Marina Picillo2, Paolo Barone2, Lucio Santoro2.   

Abstract

OBJECTIVE: To study small and large fiber pathology in drug-naive and l-dopa-treated patients affected by Parkinson disease (PD) in early phases, before the occurrence of neuropathic electrophysiologic abnormalities.
METHODS: We enrolled 85 patients with idiopathic PD (male/female 49/36, age 61.3 ± 9.7 years) without electrophysiologic signs of neuropathy, including 48 participants naive to l-dopa treatment. All patients underwent clinical, functional, and morphologic assessment of sensory and autonomic nerves through dedicated questionnaires, quantitative sensory testing, sympathetic skin response, dynamic sweat test, and punch biopsies from glabrous and hairy skin. Sensory and autonomic innervation was visualized with specific antibodies and analyzed by confocal microscopy. Data were compared with those obtained from sex- and age-comparable healthy controls. In 35 patients, skin biopsies were performed bilaterally to evaluate side-to-side differences.
RESULTS: Intraepidermal nerve fiber density was lower in patients compared to controls in all the examined sites (p < 0.001). The loss was higher in the more affected side (p < 0.01). A loss of autonomic nerves to vessels, sweat glands, and arrector pili muscles and of Meissner corpuscles and their myelinated endings in glabrous skin was found (p < 0.001). Patients showed increased tactile and thermal thresholds, impairment of mechanical pain perception, and reduced sweat output (p < 0.001). The naive and l-dopa-treated groups differed only for Meissner corpuscle density (p < 0.001).
CONCLUSIONS: Both large and small fiber pathology occurs in the early stages of PD and may account for the sensory and autonomic impairment. l-Dopa affects the 2 populations of fibers differently.
© 2017 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28747449     DOI: 10.1212/WNL.0000000000004274

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

1.  Postganglionic Sudomotor Assessment in Early Stage of Multiple System Atrophy and Parkinson Disease: A Morpho-functional Study.

Authors:  Vincenzo Provitera; Valeria Iodice; Fiore Manganelli; Stefania Mozzillo; Giuseppe Caporaso; Annamaria Stancanelli; Ilaria Borreca; Marcello Esposito; Raffaele Dubbioso; Rosa Iodice; Floriana Vitale; Shiwen Koay; Ekawat Vichayanrat; Fernanda Valerio; Lucio Santoro; Maria Nolano
Journal:  Neurology       Date:  2022-01-11       Impact factor: 9.910

Review 2.  Movement disorders and neuropathies: overlaps and mimics in clinical practice.

Authors:  Francesco Gentile; Alessandro Bertini; Alberto Priori; Tommaso Bocci
Journal:  J Neurol       Date:  2022-06-03       Impact factor: 6.682

3.  Skin Temperature in Parkinson's Disease Measured by Infrared Thermography.

Authors:  Mathias Møller Purup; Karoline Knudsen; Pall Karlsson; Astrid Juhl Terkelsen; Per Borghammer
Journal:  Parkinsons Dis       Date:  2020-07-25

4.  Effectiveness of Topical Lidocaine-Prilocaine Cream for Pain Control During Femoral Artery Catheterization in Adult Patients: A Prospective Study.

Authors:  Adnan I Qureshi; Muhammad A Saleem; Nishath Naseem; Emrah Aytac; Cetin Kursad Akpinar; Shawn S Wallery
Journal:  J Vasc Interv Neurol       Date:  2018-06

Review 5.  Pain in Parkinson's disease and the role of the subthalamic nucleus.

Authors:  Abteen Mostofi; Francesca Morgante; Mark J Edwards; Peter Brown; Erlick A C Pereira
Journal:  Brain       Date:  2021-06-22       Impact factor: 13.501

Review 6.  Levodopa-Induced Neuropathy: A Systematic Review.

Authors:  Alberto Romagnolo; Aristide Merola; Carlo Alberto Artusi; Mario Giorgio Rizzone; Maurizio Zibetti; Leonardo Lopiano
Journal:  Mov Disord Clin Pract       Date:  2018-11-08

7.  Multidimensional Circadian Monitoring by Wearable Biosensors in Parkinson's Disease.

Authors:  Carlos J Madrid-Navarro; Francisco Escamilla-Sevilla; Adolfo Mínguez-Castellanos; Manuel Campos; Fernando Ruiz-Abellán; Juan A Madrid; M A Rol
Journal:  Front Neurol       Date:  2018-03-26       Impact factor: 4.003

8.  Long-term Efficacy of Safinamide on Parkinson's Disease Chronic Pain.

Authors:  Carlo Cattaneo; Jaime Kulisevsky; Viviana Tubazio; Paola Castellani
Journal:  Adv Ther       Date:  2018-03-14       Impact factor: 3.845

Review 9.  Should Skin Biopsies Be Performed in Patients Suspected of Having Parkinson's Disease?

Authors:  Timo Siepmann; Ana Isabel Penzlin; Ben Min-Woo Illigens; Heinz Reichmann
Journal:  Parkinsons Dis       Date:  2017-10-30

10.  Cervical skin denervation associates with alpha-synuclein aggregates in Parkinson disease.

Authors:  Giorgia Melli; Elena Vacchi; Vanessa Biemmi; Salvatore Galati; Claudio Staedler; Roberto Ambrosini; Alain Kaelin-Lang
Journal:  Ann Clin Transl Neurol       Date:  2018-10-14       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.